Further pieces of evidence came from the NKG2A neutralization in tumor models exposed to radiotherapy, which upregulates Qa‐1b expression and compromises the anti‐tumor efficacy mediated by anti‐PD‐1 mAbs (Battaglia et al, 2022). Here, KLRC1 is linked to neoplasm.